IHH, a major player in healthcare services, is planning to boost its control over Fortis Health by purchasing additional shares, aiming to raise their stake to half of the company.

IHH Healthcare is increasing its investments in India by channeling funds through Fortis Healthcare, according to reports on CNBC TV18. This move indicates a strengthened commitment from IHH Healthcare towards the Indian healthcare sector.

Fortis aims to increase its ownership from 31% to 50%, and plans to boost bed capacity to 10,000 by 2030. IHH Healthcare's CEO has confirmed their readiness to provide capital for significant M&A deals, such as hospital acquisitions.

IHH Healthcare intends to grow in India by leveraging acquisitions of Fortis and Gleneagles, having resolved legal complications. This move will bolster their existing presence within the Indian healthcare market.

Endurance Tech remains a Buy recommendation by Citi, yet the target price is revised down to Rs 2,900 due to demand concerns. The financial services firm Fortis Healthcare expects an EBITDA margin of 22-25% by FY26. Jefferies predicts a 74% growth potential for Aavas Financiers, setting a target price at Rs 1,875. However, Morgan Stanley expresses caution and prefers Aptus and Home First Finance over Aavas Financiers.